AU7632198A - Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof - Google Patents

Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof

Info

Publication number
AU7632198A
AU7632198A AU76321/98A AU7632198A AU7632198A AU 7632198 A AU7632198 A AU 7632198A AU 76321/98 A AU76321/98 A AU 76321/98A AU 7632198 A AU7632198 A AU 7632198A AU 7632198 A AU7632198 A AU 7632198A
Authority
AU
Australia
Prior art keywords
paclitaxel
ready
preparing
pharmaceutical form
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76321/98A
Other languages
English (en)
Inventor
Joszef Geczy
Freddy Louvet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES THISSEN
Original Assignee
THISSEN LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THISSEN LAB filed Critical THISSEN LAB
Publication of AU7632198A publication Critical patent/AU7632198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76321/98A 1997-06-13 1998-06-02 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof Abandoned AU7632198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700515 1997-06-13
BE9700515A BE1011216A3 (fr) 1997-06-13 1997-06-13 Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
PCT/BE1998/000078 WO1998057630A1 (fr) 1997-06-13 1998-06-02 Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition

Publications (1)

Publication Number Publication Date
AU7632198A true AU7632198A (en) 1999-01-04

Family

ID=3890575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76321/98A Abandoned AU7632198A (en) 1997-06-13 1998-06-02 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof

Country Status (5)

Country Link
AR (1) AR012972A1 (fr)
AU (1) AU7632198A (fr)
BE (1) BE1011216A3 (fr)
WO (1) WO1998057630A1 (fr)
ZA (1) ZA984832B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
DE60136648D1 (de) 2000-12-05 2009-01-02 Los Angeles Childrens Hospital Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
EP1498143A1 (fr) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Formulations auto-émulsifiantes et auto-microémulsifiantes pour l'administration orale de taxoides
EP1648988A1 (fr) * 2003-07-24 2006-04-26 Dabur Research Foundation Procede de purification de solvants non ioniques pour preparations pharmaceutiques injectables stabilisees
US20050016926A1 (en) 2003-07-24 2005-01-27 Dabur Research Foundation Stabilized formulation
CN1853728A (zh) * 2005-04-19 2006-11-01 上海天博生物科技有限公司 一种改善药物或营养物口服吸收的方法、配方及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
CA2149150C (fr) * 1992-11-27 2000-08-01 David R. Carver Composition injectable de taxol plus stable
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel

Also Published As

Publication number Publication date
WO1998057630A1 (fr) 1998-12-23
BE1011216A3 (fr) 1999-06-01
AR012972A1 (es) 2000-11-22
ZA984832B (en) 1999-01-04

Similar Documents

Publication Publication Date Title
IL145983A0 (en) Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof
ZA962536B (en) Pharmaceutical composition for transdermal administration.
PL354322A1 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
ZA200000842B (en) Method and system for administering a medication.
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
AU7640696A (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
HUP0001494A3 (en) 3-phenoxy-, 3-dibenzo[a,d]cycloheptenyloxy-, 3-dibenz[b,f][1,4]oxazepinyloxy-1-amino-2-propanol derivatives and pharmaceutical compositions containing them
HK1022271A1 (en) Pharmaceutical aerosol composition.
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
AU1689999A (en) Medicinal composition for percutaneous administration
AU7534794A (en) A method and pharmaceutical compositions for drug targeting
AU2345695A (en) Pharmaceutical composition for transdermal delivery
HUP0001551A3 (en) Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same
AU7632198A (en) Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU8031598A (en) 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
AU5406099A (en) A pharmaceutical composition containing calcineurin b subunit
AU7655694A (en) A method and pharmaceutical and diagnosis compositions for drug targeting
AU3393600A (en) Method for safely and effectively administering a drug by inhalation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase